Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.dsx.2021.02.026 http://scihub22266oqcxt.onion/10.1016/j.dsx.2021.02.026 33662837!7904463!33662837     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 249.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diabetes+Metab+Syndr 2021 ; 15 (2): 505-508 Nephropedia Template TP {{tp|p=33662837|t=2021. COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges |pdf=|usr=}}{{33662837}} gab.com Text COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges JO: Diabetes Metab Syndr http://www.kidney.de/pget.php?&tw=1&pmid=33662837 #FOAvip BACKGROUND AND AIMS: To summarize the available evidence on the use COVID-19 vaccines in patients with diabetes mellitus. METHODS: We performed a thorough literature search with regard to COVID-19 vaccines in patients with type 1 and type 2 diabetes mellitus. RESULTS: The novel coronavirus disease (COVID-19) tends to portend a poor prognosis in patients with diabetes mellitus (DM). Primary prevention remains the mainstay for mitigating the risks associated with COVID-19 in patients with DM. A significant step in primary prevention is timely vaccination. Routine vaccination against pneumococcal pneumonia, influenza, and hepatitis B is recommended in patients with DM with good efficacy and reasonable safety profile. With clinical data supporting a robust neutralizing antibody response in COVID-19 patients with DM, vaccination in individuals with DM is justified. In fact, as the burden of the disease is borne by people with DM, COVID-19 vaccination should be prioritized in individuals with DM. Multiple unresolved issues with regard to preferred vaccine type, vaccine efficacy and durability, frequency of administration, vaccination in children (<18 years) and pregnant/lactating women however remain, and need to be addressed through future research. CONCLUSIONS: Patients with type 1 and type 2 diabetes mellitus are at a high risk of poor prognosis with COVID-19 and vaccination should be prioritized in them. However, many unresolved issues with regard to COVID-19 vaccination need to be addressed through future research. Twit Text FOAVip COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges ????Diabetes Metab Syndr http://www.kidney.de/pget.php?&tw=1&pmid=33662837 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33662837 #FOAvip English Wikipedia <ref>{{Cite pmid|33662837}}</ref> COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges #MMPMID33662837 Pal R; Bhadada SK; Misra A Diabetes Metab Syndr 2021[Mar]; 15 (2): 505-508 PMID33662837show ga BACKGROUND AND AIMS: To summarize the available evidence on the use COVID-19 vaccines in patients with diabetes mellitus. METHODS: We performed a thorough literature search with regard to COVID-19 vaccines in patients with type 1 and type 2 diabetes mellitus. RESULTS: The novel coronavirus disease (COVID-19) tends to portend a poor prognosis in patients with diabetes mellitus (DM). Primary prevention remains the mainstay for mitigating the risks associated with COVID-19 in patients with DM. A significant step in primary prevention is timely vaccination. Routine vaccination against pneumococcal pneumonia, influenza, and hepatitis B is recommended in patients with DM with good efficacy and reasonable safety profile. With clinical data supporting a robust neutralizing antibody response in COVID-19 patients with DM, vaccination in individuals with DM is justified. In fact, as the burden of the disease is borne by people with DM, COVID-19 vaccination should be prioritized in individuals with DM. Multiple unresolved issues with regard to preferred vaccine type, vaccine efficacy and durability, frequency of administration, vaccination in children (<18 years) and pregnant/lactating women however remain, and need to be addressed through future research. CONCLUSIONS: Patients with type 1 and type 2 diabetes mellitus are at a high risk of poor prognosis with COVID-19 and vaccination should be prioritized in them. However, many unresolved issues with regard to COVID-19 vaccination need to be addressed through future research. |*Diabetes Mellitus, Type 1[MESH] |*Diabetes Mellitus, Type 2[MESH] |2019-nCoV Vaccine mRNA-1273[MESH] |Ad26COVS1[MESH] |Antibodies, Neutralizing/immunology[MESH] |BNT162 Vaccine[MESH] |COVID-19 Vaccines/*therapeutic use[MESH] |COVID-19/*prevention & control[MESH] |ChAdOx1 nCoV-19[MESH] |Humans[MESH] |Risk Factors[MESH]COVID-19 vaccination in patients with diabetes mellitus: Current conce(epmc).pdf DeepDyve Pubget Overpricing